MeSH D007898 - visceral leishmaniasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Amphotericin b | Amphotericin B |  | 1995-03-31 |  |  |
| Hospira | Pentamidine isethionate | Pentamidine Isethionate |  | 1992-06-30 |  |  |
| Bristol Myers Squibb | Amphotericin b | Fungizone |  | 1982-01-01 |  |  |
| Sun Pharmaceuticals | Amphotericin b | Amphotericin B |  | 2021-12-14 |  |  |
| Astellas Pharma | Amphotericin b | Ambisome |  | 1997-08-11 |  |  |
| Abbott Biotherapeutics | Amphotericin b | Amphotericin B |  | 1996-12-23 |  |  |
| GE Healthcare | Meglumine, Metrizoic acid | Isopaque |  | 1982-01-01 |  |  |
| Knight Therapeutics | Miltefosine | Impavido |  | 2014-03-19 |  |  |
| Leadiant Biosciences | Amphotericin b | Abelcet |  | 1995-11-20 |  |  |
| Eugia Pharma Specialties | Amphotericin b | Amphotericin B |  | 2022-11-17 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
100%2/2
Phase 2
67%2/3
Phase 3
92%11/12
Approved: 5Overall Success rate: 61%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use